Hair loss
1 paper2 findings
Associations
2Weight reduction
upin humans1
1 study
Weight reduction
upin humans1
Weight reduction predicts hair loss in humans.
“Female sex and significant weight reduction (> 10%) were the most robust predictors of hair loss.”
Reviewweight reduction > 10% during incretin-based therapy
GLP-1 receptor agonists and hair loss: adverse effect, epiphenomenon, or therapeutic paradox?
Acta diabetologica14 Oct 2026
Incretin-based therapies
upin humans1
1 study
Incretin-based therapies
upin humans1
Incretin-based therapies are associated with hair loss in humans (Prevalence 3–7% in controlled trials; over 70% in real-world cohorts).
“There is a discrepancy in hair loss prevalence, ranging from 3 to 7% in controlled trials to over 70% in real-world cohorts.”
Reviewincretin-based therapy use
GLP-1 receptor agonists and hair loss: adverse effect, epiphenomenon, or therapeutic paradox?
Acta diabetologica14 Oct 2026
Trial sponsors
Company1 trialPhase 375 people
Company1 trialEarly phase 116 people
Chia Nan University of Pharmacy & Science
1 trial40 people
Latest
14 in 12 monthsCureus
Male Senescence Phenotypes Include Hair Loss and Hair Gain
Cross-sectional study in peoplePopulations
The Laryngoscope
Nonscarring Alopecia in Adults Treated With GLP-1s: A Propensity Score Matched TriNetX Cohort Study
Cohort study in peopleInterventions
Expert Opinion on Pharmacotherapy
Emerging pharmacotherapies for androgenetic alopecia
ReviewInterventions
ADA Scientific Sessions 2026 Abstract
Comparing Adverse Event Rates among GLP-1/GIP Therapy Switchers vs. Continuous Use Groups in a Real-World Telehealth Cohort
Cohort study in peopleInterventions